ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682825 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682825; 2) Community: the network communities that were significantly associated with the response to NSC 682825; 3) Molecule: the relationships between components within communities and NSC 682825; 4) MDR: the compounds that were significantly associated with the NSC 682825.

NSC Compound Enrichment Correlation
NSC 381866 BAFILOMYCIN DERIV. 0.00036608087748593 0.18558588
NSC 625494 Null 0.00036608087748593 0.60138667
NSC 634784 4-Piperidinone, 1-[3-(dimethylamino)-1-oxopropyl]-3,5- bis(phenylmethylene)-, monohydrochloride 0.00036608087748593 0.48431167
NSC 668300 Null 0.00036608087748593 0.19672244
NSC 683564 2-Butenoic acid, 4,4-dicyano-4-[[(3-thienyl)methylene]amino]-, methyl ester, (Z,E)- 0.000366080877485931 0.82667712
NSC 718530 Null 0.000366080877485931 0.53474321
NSC 720340 Null 0.000366080877485933 0.32719428
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.000366080877485933 0.052485459
NSC 754241 6-(2-(dimethylamino)ethoxy)-9-methoxy-11H-indeno[1,2-c]quinolin-11-one 0.000366080877485933 0.31414675
NSC 756471 SB-732941 0.000366080877485933 0.18938172
Total:161  Current:6    [First] [Prev] [Next] [Last]